SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:oru-63630"
 

Sökning: id:"swepub:oai:DiVA.org:oru-63630" > Secreted frizzled-r...

  • Lagathu, C.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)

Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity.

  • Artikel/kapitelEngelska2010

Förlag, utgivningsår, omfång ...

  • 2010-06-01
  • London, United Kingdom :Nature Publishing Group,2010
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-63630
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-63630URI
  • https://doi.org/10.1038/ijo.2010.107DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies:Biotechnology and Biological Science Research Council (BBSRC) Medical Research Council (MRC) ALFEDIAM Marie Curie Post-doctoral fellowship 
  • AIM: The Wnt/β-catenin signaling network offers potential targets to diagnose and uncouple obesity from its metabolic complications. In this study, we investigate the role of the Wnt antagonist, secreted frizzled-related protein 1 (SFRP1), in promoting adipogenesis in vitro and adipose tissue expansion in vivo.METHODS: We use a combination of human and murine, in vivo and in vitro models of adipogenesis, adipose tissue expansion and obesity-related metabolic syndrome to profile the involvement of SFRP1.RESULTS: SFRP1 is expressed in both murine and human mature adipocytes. The expression of SFRP1 is induced during in vitro adipogenesis, and SFRP1 is preferentially expressed in mature adipocytes in human adipose tissue. Constitutive ectopic expression of SFRP1 is proadipogenic and inhibits the Wnt/β-catenin signaling pathway. In vivo endogenous levels of adipose SFRP1 are regulated in line with proadipogenic states. However, in longitudinal studies of high-fat-diet-fed mice, we observed a dynamic temporal but biphasic regulation of endogenous SFRP1. In agreement with this profile, we observed that SFRP1 expression in human tissues peaks in patients with mild obesity and gradually falls in morbidly obese subjects.CONCLUSIONS: Our results suggest that SFRP1 is an endogenous modulator of Wnt/β-catenin signaling and participates in the paracrine regulation of human adipogenesis. The reduced adipose expression of SFRP1 in morbid obesity and its knock-on effect to prevent further adipose tissue expansion may contribute to the development of metabolic complications in these individuals.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Christodoulides, C.Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK (författare)
  • Tan, C. Y.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)
  • Virtue, S.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)
  • Laudes, M.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)
  • Campbell, M.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)
  • Ishikawa, K.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)
  • Ortega, F.Department of Diabetes, Endocrinology and Nutrition, Hospital of Girona Dr. Josep Trueta, Biomedical Research Institute and CIBEROBN Fisiopatología de la Obesidad y Nutrición, Girona, Spain (författare)
  • Tinahones, F. J.Service of Endocrinology and Nutrition, Hospital Clinico Universitario Virgen de Victoria de Malaga, Malaga, Spain (författare)
  • Fernández-Real, J.-M.Department of Diabetes, Endocrinology and Nutrition, Hospital of Girona Dr. Josep Trueta, Biomedical Research Institute and CIBEROBN Fisiopatología de la Obesidad y Nutrición, Girona, Spain (författare)
  • Oresic, Matej,1967-VTT Technical Research Centre of Finland, Espoo, Finland(Swepub:oru)moc (författare)
  • Sethi, J. K.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)
  • Vidal-Puig, A.Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (författare)
  • Institute of Metabolic Science – Metabolic Research Laboratories, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UKOxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:International Journal of ObesityLondon, United Kingdom : Nature Publishing Group34:12, s. 1695-17050307-05651476-5497

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy